Public health campaigners on Tuesday accused Pfizer of putting profits over human life after the U.S.-based pharmaceutical giant raised its coronavirus vaccine sales projection to $36 billion for 2021, a move that came as the company faced backlash for denying shots to pandemic-ravaged poor countries. Pfizer announced Tuesday that it raked in $24.1 billion in total revenue in the third quarter, $13 billion of which was attributable to Comirnaty, the Covid-19 vaccine the company makes with its German partner BioNTech—with the help of public funding and U.S. government technology.
— source commondreams.org | Nov 2, 2021